Skip to main content

Advertisement

SpringerLink
Log in

The real risk of nodal disease in T1 oesophageal adenocarcinoma

A systematic review

  • review
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

Background

Lymph node status is regarded as an important factor in the prognosis of oesophageal cancer. T1 oesophageal adenocarcinoma management has to include endoscopic management as part of the algorithm. We reviewed the literature to assess the true risk of lymph node metastasis in patients with T1 oesophageal adenocarcinoma.

Methods

Medline, Embase, PubMed and Cochrane where searched for manuscripts in English reviewing lymph node metastasis in superficial (T1) oesophageal adenocarcinoma. The main outcome was probability of lymph node metastasis in T1a and T1b oesophageal adenocarcinoma. Secondary outcome was the rate of lymph node metastasis of submucosal involvement of T1b (SM1, SM2 and SM3).

Results

There were 38 studies identified. 22 studies were excluded due to low lymph node yield (<15) or insufficient statistical analysis. For the 16 remaining studies, a total of 1382 cases were included: T1a adenocarcinoma (533 patients) with 11 (2%) node positive and T1b adenocarcinoma (849 patients) with 189 (22%) node positive. Subgroup analysis of T1b lesions was available in 8 reports (365 patients). Node positivity for SM1, SM2 and SM3 was 19.9%, 20.2% and 32.9%, respectively.

Conclusion

T1a disease on endoscopic mucosal resection (EMR) demonstrates a 2% nodal metastasis rate, T1b disease a rate of 22%. T1a disease may be safely treated by EMR. T1a disease appears suitable for endoscopic therapy; however, T1b disease presents a high rate of nodal metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

Cited Literature

  1. Ajani JA, et al. Esophageal and Esophagogastric Junction Cancers, version2.2019, NCCNClinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 2019;17(7):855–883

    PubMed  Google Scholar 

  2. Chadwick G, Varagunam M, Brand C, et al. National Oesophag-Gastric Cancer Audit. An Audit of the care received by people with Oesophago-Gastric Cancer in England and Wales. Ninth Annual Report 2016. L.N.I. Centre; 2016.

  3. Nobel T, et al. Ongoing challenges with clinical assessment of nodal status in T1 esophageal adenocarcinoma. J Am Coll Surg. 2018;229(4):366–73.

    Google Scholar 

  4. van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.

    PubMed  Google Scholar 

  5. Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

    CAS  PubMed  Google Scholar 

  6. Gockel I, et al. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J Surg Oncol. 2009;100(3):191–8.

    CAS  PubMed  Google Scholar 

  7. Stein HJ, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242(4):566–73. discussion 573–575.

    PubMed  PubMed Central  Google Scholar 

  8. Holscher AH, et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg. 2011;254(5):802–7. discussion 807–808.

    PubMed  Google Scholar 

  9. Sepesi B, et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg. 2010;210(4):418–27.

    PubMed  Google Scholar 

  10. Nigro JJ, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg. 1999;117(1):16–23. discussion 23–25.

    CAS  PubMed  Google Scholar 

  11. Griffin SM, Burt AD, Jennings NA. Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg. 2011;254(5):731–6. discussion 736–737.

    CAS  PubMed  Google Scholar 

  12. Badreddine RJ, Prasad G, Lewis JT, Lutzke LS, Borkenhagen LS, Dunagan KT, et al. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol. 2010;8(3):248–53.

    PubMed  Google Scholar 

  13. Manner H, et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29(7):1888–96.

    PubMed  Google Scholar 

  14. Leers JM, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg. 2011;253(2):271–8.

    PubMed  Google Scholar 

  15. Gertler R, et al. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg. 2014;259(1):96–101.

    PubMed  Google Scholar 

  16. Lee L, et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg. 2013;217(2):191–9.

    PubMed  Google Scholar 

  17. Nentwich MF, et al. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg. 2014;18(2):242–9. discussion 249.

    PubMed  Google Scholar 

  18. Bogoevski D, et al. How radical should surgery be for early esophageal cancer? World J Surg. 2011;35(6):1311–20.

    PubMed  Google Scholar 

  19. Hagen JA, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234(4):520–30. discussion 530–531.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Molena D, et al. Esophagectomy following endoscopic resection of submucosal esophageal cancer: a highly curative procedure even with nodal metastases. J Gastrointest Surg. 2017;21(1):62–7.

    PubMed  Google Scholar 

  21. Bollschweiler E, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006;38(2):149–56.

    CAS  PubMed  Google Scholar 

  22. Samson P, et al. Adhering to quality measures in esophagectomy is associated with improved survival in all stages of esophageal cancer. Ann Thorac Surg. 2017;103(4):1101–8.

    PubMed  PubMed Central  Google Scholar 

  23. Altorki NK, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg. 2008;247(3):434–9.

    PubMed  Google Scholar 

  24. Greenstein AJ, et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg. 2008;206(2):239–46.

    PubMed  Google Scholar 

  25. Peyre CG, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248(4):549–56.

    PubMed  Google Scholar 

  26. Rizk NP, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46–50.

    PubMed  Google Scholar 

  27. Rösch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am. 1995;5(3):537–47.

    PubMed  Google Scholar 

  28. Sandha GS, et al. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Gastrointest Endosc. 2008;67(3):402–9.

    PubMed  Google Scholar 

  29. Cuellar SL, et al. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol. 2014;9(8):1202–6.

    CAS  PubMed  Google Scholar 

  30. van Vliet EP, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547–57.

    PubMed  PubMed Central  Google Scholar 

  31. Ell C, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc. 2007;65(1):3–10.

    PubMed  Google Scholar 

  32. Pech O, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–660e1.

    PubMed  Google Scholar 

  33. Manner H, et al. Long-term results of endoscopic resection in early gastric cancer: the Western experience. Am J Gastroenterol. 2009;104(3):566–73.

    PubMed  Google Scholar 

  34. Collard JM. High-grade dysplasia in Barrett’s esophagus. The case for esophagectomy. Chest Surg Clin N Am. 2002;12(1):77–92.

    PubMed  Google Scholar 

  35. Van Vilsteren FG, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut. 2011;60(6):765–73.

    PubMed  Google Scholar 

  36. Phoa KN, et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut. 2016;65(4):555–62.

    CAS  PubMed  Google Scholar 

  37. Orman ES, et al. Efficacy and durability of radiofrequency ablation for Barrett’s Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(10):1245–55.

    PubMed  Google Scholar 

  38. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach and colon. GastroIntest Endo. 2003;58(6Suppl):S3-43

  39. Weusten B, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49:2589–97.

    Google Scholar 

  40. Manner H, et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008;103(10):2589–97.

    PubMed  Google Scholar 

  41. Alvarez Herrero L, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy. 2010;42(12):1030–6.

    CAS  PubMed  Google Scholar 

  42. Bergman JJ. UPTODATE.COM. 2017. www.uptodate.acs.hcm.com. Accessed: 11 July 2018.

  43. Ancona E, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008;15(11):3278–88.

    PubMed  Google Scholar 

  44. Wani S, et al. Comparison of endoscopic therapies and surgical resection in patients with oesophageal cancer: a population-based study. Gastrointest Endosc. 2014;79(2):224–32.

    PubMed  Google Scholar 

  45. Pennathur A, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87(4):1048–54. discussion 1054–1055.

    PubMed  PubMed Central  Google Scholar 

  46. Rice TW, et al. 8th edition AJCC/UICC staging of cancers of the esophahstric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119–30.

    PubMed  PubMed Central  Google Scholar 

Further Reading

  1. American Cancer Society. Cancer Facts and Figures. Atlanta: Ga; 2016. Available from: http://www.cancer.org/cancer/esophaguscancer/detailedguide/esophagus-cancer-survival-rates.

    Google Scholar 

Download references

Acknowledgements

To Suzanna Gooley for editorial assistance.

Author information

Authors and Affiliations

  1. Concord Hospital, Hospital Road, 2129, Concord, NSW, Australia

    David P. Mitchell BSc MBBS FRACS, Sashi Yeluri MBBS FRCS & Gregory L. Falk MBBS FRCS FRACS

  2. CNI medical imaging, Meadowbank, New South Wales, Australia

    Hans Van der Wall PhD, FRACP

  3. Suite 29, 12 Tryon Road, 2070, Lindfield, NSW, Australia

    Gregory L. Falk MBBS FRCS FRACS

Authors
  1. David P. Mitchell BSc MBBS FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sashi Yeluri MBBS FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Van der Wall PhD, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gregory L. Falk MBBS FRCS FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory L. Falk MBBS FRCS FRACS.

Ethics declarations

Conflict of interest

D.P. Mitchell, S. Yeluri, H. Van der Wall and G.L. Falk declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mitchell, D.P., Yeluri, S., Van der Wall, H. et al. The real risk of nodal disease in T1 oesophageal adenocarcinoma. Eur Surg 52, 110–117 (2020). https://doi.org/10.1007/s10353-019-00627-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-019-00627-x

Keywords

Search

Navigation